Portfolio & Asset Strategy Vendors

Compare advisors for portfolio and asset strategy: prioritizing assets, sequencing indications, lifecycle strategy and resource allocation.

Related workflows

Blue Matter Consulting is a strategic consulting firm providing launch readiness, portfolio strategy, market access, and medical affairs planning.

Products: Twine, Narralytix +1 more

Evidence-backed capability match
Matches Portfolio & Asset Strategy
“We help customers optimize their investments across therapeutic areas and across assets within any given therapeutic portfolio.”
Source: bluematterconsulting.com

Also offers: Product Launch Strategy & Readiness, Market Access Strategy & Launch Planning, +1 more

Evaluate provides pharma intelligence, forecasting software, analytics, data delivery, and consulting for portfolio and commercial decisions.

Products: Evaluate Pharma, Evaluate Omnium

Evidence-backed capability match
Matches Portfolio & Asset Strategy
“With a team of over 70 consultants globally, extensive data assets, and experience across therapy areas and modalities, we specialise in the areas of Portfolio Strategy, Licensing…”
Source: evaluate.com

Also offers: Competitive Intelligence, Business Development, Licensing & Due Diligence, +1 more

ZS is a life-sciences consulting, technology and data firm providing commercial strategy, market access, medical affairs and clinical planning services.

Products: ZAIDYN, ZS Trials.ai +3 more

Evidence-backed capability match
Matches Portfolio & Asset Strategy
“…ZS’s approach to portfolio strategy and management Deliver greater portfolio value, leveraging ZS’s deep industry expertise and advanced analytics to create actionable strategies…”
Source: zs.com

Also offers: Segmentation, Targeting & Call Planning, Medical Insights Management, +6 more

Halloran Consulting Group is a life-sciences consulting firm providing regulatory strategy, dossier writing, GxP quality, and clinical trial management.
Evidence-backed capability match
Matches Portfolio & Asset Strategy
“Indication Assessment and Prioritization (IAP) forms the cornerstone of strategic evaluation for identified indications, leveraging key parameters to determine their potential…”
Source: hallorancg.com

Also offers: Regulatory Development Strategy & Agency Interactions, GxP Compliance Consulting, +2 more

Lumanity is a life sciences consultancy for market access strategy, health economic modeling, brand positioning and scientific communications.

Products: Lumanity Illuminator, Evidence Illuminator +9 more

Evidence-backed capability match
Matches Portfolio & Asset Strategy
“Prioritizing and sequencing your pipeline for your programs or platform at an early stage, while considering future factors such as clinical feasibility, regulatory agencies, and…”
Source: lumanity.com

Also offers: Market Access Strategy & Launch Planning, Brand Strategy & Positioning, +2 more

Trinity Life Sciences is a commercialization intelligence partner offering market access strategy, launch strategy, forecasting and market research.

Products: TrinityEDGE, InsightsEDGE +6 more

Evidence-backed capability match
Matches Portfolio & Asset Strategy
“Analysis: Valuations, profitability, risk-adjusted portfolio assessments, and peer benchmarking”
Source: trinitylifesciences.com

Also offers: Market Research & Primary Insights, Product Launch Strategy & Readiness, +2 more

Envision Pharma Group is an agency and technology platform for publication planning, scientific communications, and value dossiers.
Evidence-backed capability match
Matches Portfolio & Asset Strategy
“Asset and development strategy, feasibility, and integrated evidence generation and planning.”
Source: envisionpharmagroup.com

Also offers: Publication Planning & Management, Scientific Communications Strategy, +1 more

OPEN Health is a consulting and agency partner providing HTA strategy and submissions, RWE for HEOR, and scientific communications services.
Evidence-backed capability match
Matches Portfolio & Asset Strategy
“…Beyond the Asset Decisions don’t happen in isolation. We help clients think across therapy areas and portfolios, identifying where science aligns, where unmet need clusters, and…”
Source: openhealthgroup.com

Also offers: HTA Strategy & Submissions, RWE for Access & HEOR, +3 more

IQVIA is a CRO and technology provider delivering clinical trials, real-world evidence, commercial intelligence and safety operations.

Products: IQVIA Vigilance Platform, SmartSolve +4 more

Evidence-backed capability match
Matches Portfolio & Asset Strategy
“…Enhance your portfolio strategy and manage risk effectively with evidence-based decisions. Understand market dynamics, evaluate pipeline assets and prioritize products based on…”
Source: iqvia.com

Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more

Compare listed vendors

What this covers: Advisory services focused on prioritizing assets, optimizing portfolios, sequencing indications, lifecycle strategy, resource allocation, and strategic decisions across pipeline or marketed product portfolios.

VendorDelivery modelAlso offersIn their words
Blue Matter ConsultingConsulting / Advisory FirmCorporate & Growth Strategy, R&D and Innovation Strategy“We help customers optimize their investments across therapeutic areas and across assets within any given therapeutic portfolio.”bluematterconsulting.com · reviewed Oct 21, 2026
Envision Pharma GroupAgency—“Asset and development strategy, feasibility, and integrated evidence generation and planning.”envisionpharmagroup.com · reviewed Oct 18, 2026
EvaluateData / Intelligence ProviderCorporate & Growth Strategy“With a team of over 70 consultants globally, extensive data assets, and experience across therapy areas and modalities, we specialise in the areas of Portfolio…”evaluate.com · reviewed Oct 20, 2026
Halloran Consulting GroupConsulting / Advisory FirmR&D and Innovation Strategy“Indication Assessment and Prioritization (IAP) forms the cornerstone of strategic evaluation for identified indications, leveraging key parameters to determine…”hallorancg.com · reviewed Oct 21, 2026
IQVIACRO / Research Services Provider—“…Enhance your portfolio strategy and manage risk effectively with evidence-based decisions. Understand market dynamics, evaluate pipeline assets and prioritize…”iqvia.com · reviewed Oct 19, 2026
LumanityConsulting / Advisory FirmCorporate & Growth Strategy“Prioritizing and sequencing your pipeline for your programs or platform at an early stage, while considering future factors such as clinical feasibility…”lumanity.com · reviewed Oct 21, 2026
OPEN HealthConsulting / Advisory Firm—“…Beyond the Asset Decisions don’t happen in isolation. We help clients think across therapy areas and portfolios, identifying where science aligns, where unmet…”openhealthgroup.com · reviewed Oct 24, 2026
Trinity Life SciencesService ProviderCorporate & Growth Strategy“Analysis: Valuations, profitability, risk-adjusted portfolio assessments, and peer benchmarking”trinitylifesciences.com · reviewed Oct 21, 2026
ZSConsulting / Advisory FirmCorporate & Growth Strategy, R&D and Innovation Strategy“…ZS’s approach to portfolio strategy and management Deliver greater portfolio value, leveraging ZS’s deep industry expertise and advanced analytics to create…”zs.com · reviewed Oct 24, 2026